5AM Ventures Beats Goal for 3rd Fund

5AM Ventures, a life sciences-focused early stage venture capital firm, has surpassed its $150 million target for its third fund, reports PE Hub. An SEC filing that indicates 5AM, which has offices in Waltham, MA, and Menlo Park, CA, has raised $159.2 million from 34 investors. Companies in the firm’s portfolio include Pulmatrix, a Lexington, MA-based startup developing an aerosol treatment for flu other pathogens, and Cambridge, MA-based Semprus BioSciences, which is making polymers that bond to the surface of medical devices to prevent clots and infections and to promote healing.

Author: Roxanne Palmer

Roxanne Palmer is interning at Xconomy's Boston office this summer. She is currently pursuing a master's degree in science and medical Journalism at Boston University after graduating from Brown in 2008 with a degree in English. Her thesis was on Herman Melville's Civil War poetry. When not chronicling the ups and downs of Boston's tech industry, Roxanne enjoys drawing, swimming, and birdwatching. Follow her on Twitter at http://twitter.com/roxannedpalmer, or email her at [email protected].